E Tack 150 mg (Tablet)
Unit Price: ৳ 2.38 (100's pack: ৳ 238.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Reliance pharmaceuticals ltd |
Product Title
- E Tack Ranitidine Tablet & Syrup
Categories
- Gastric Medication
- Ulcer Treatment
- Reflux Medication
Description
- E Tack is indicated for the treatment of active duodenal ulcer, benign gastric ulcer, ulcer associated with non-steroidal anti-inflammatory agents, postoperative stress ulcer, Zollinger-Ellison Syndrome, and Gastroesophageal reflux disease (GERD). It competitively blocks histamine at H2-receptors to inhibit gastric acid secretion.
Dosage Form
- Tablet
- Syrup
- IV Injection
- IV Infusion
- Intramuscular Injection
Dosage
- 150 mg twice daily for duodenal and gastric ulcer
- 150 mg twice daily for reflux oesophagitis
- 150 mg 3 times daily for Zollinger Ellison syndrome
- 150 mg twice daily for episodic dyspepsia
- 150 mg at night for maintenance
- 2-4 mg/kg twice daily for children with peptic ulcer
- 50 mg slow intravenous injection every 6-8 hours for haemorrhage prophylaxis
- Continuous intravenous infusion for upper gastrointestinal haemorrhage prophylaxis
- 2 mg/kg to 4 mg/kg twice daily for children's peptic ulcer
Interactions
- Delayed absorption with propantheline bromide
- Minimally inhibits hepatic metabolism of certain drugs
- May alter absorption of pH-dependent drugs
- May reduce bioavailability with antacids
Contraindications
- Hypersensitivity to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy & Lactation
- Ranitidine crosses the placenta
- Excreted in human breast milk
- Caution during lactation
Precautions & Warnings
- Reduced dosage for impaired renal and hepatic function
Use in Special Populations
- Similar ulcer healing rates in elderly patients compared to younger patients
Overdose Effects
- Specific in action
- Symptomatic and supportive therapy recommended
- Potential for removal by haemodialysis
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Multiple reconstitution options for IV and intramuscular administration
Storage Conditions
- Cool and dry place
- Protect from light